Probiotics, defined as live microorganisms that confer health benefits when consumed in adequate amounts, have garnered significant attention due to their vital role in maintaining gut health. Among the diverse range of probiotic strains, Bifidobacterium species have emerged as key players in promoting a balanced gut microbiota. Two notable strains, Bifidobacterium bifidum(B. bifidum) and Bifidobacterium longum(B. longum), are commonly studied for their unique properties and health benefits.
B. bifidum is a Gram-positive, anaerobic bacterium found in the intestines of humans and other mammals, especially during infancy. It is one of the first probiotics to colonize the gut and plays an essential role in maintaining a healthy balance of the gut microbiota throughout life.
Characteristic | B. bifidum |
---|---|
Gram Stain | Positive (Gram-positive) |
Oxygen Requirement | Anaerobic |
Metabolism | Ferments oligosaccharides, producing SCFAs like acetate and lactate |
Survival Factors | Bile salt and acid resistance |
Key Enzymes | Beta-galactosidase, arabinose isomerase |
B. bifidum is instrumental in maintaining a healthy gut microbiome, particularly by fermenting oligosaccharides and producing short-chain fatty acids (SCFAs). These SCFAs, such as acetate and lactate, lower the pH of the gut, inhibiting the growth of harmful pathogens. B. bifidum also helps prevent overgrowth of potentially harmful bacteria, creating a competitive environment in the gut.
B. longum is a facultative anaerobic, Gram-positive bacterium that also inhabits the human gastrointestinal tract. It is highly versatile, surviving in a wide range of environmental conditions, from the acidic environment of the stomach to the more neutral pH of the intestines. You can explore our gram staining and microscopic techniques in the microbial identification.
Characteristic | B. longum |
---|---|
Gram Stain | Positive (Gram-positive) |
Oxygen Requirement | Facultative anaerobic |
Metabolism | Ferments a variety of carbohydrates, producing lactate and acetate |
Survival Factors | Bile salt and acid tolerance |
Key Enzymes | Lactase, arabinose isomerase, xylanase |
B. longum plays a vital role in maintaining gut health by fermenting carbohydrates, which produces SCFAs like lactate and acetate. These compounds help lower the gut pH and create an environment that favors beneficial microbes over pathogens. B. longum also supports the integrity of the intestinal barrier and promotes healthy gut motility.
While both B. bifidum and B. longum contribute to gut health, their properties and effects on human health differ in several key aspects. The following table summarizes these differences:
Aspect | B. bifidum | B. longum |
---|---|---|
Biological Characteristics | Prefers anaerobic conditions; more effective in fermenting oligosaccharides. | More resilient to environmental stressors like oxygen and bile salts; ferments both simple and complex sugars, including lactose. |
Metabolic Profile | Primarily ferments complex carbohydrates, producing acetate and lactate. | Ferments both simple and complex sugars, producing more acetate than B. bifidum. |
Survival in Stressful Conditions | Thrives in environments with limited oxygen. | Greater adaptability to various environmental conditions, including oxygen-rich environments. |
Impact on Human Health | Beneficial for newborns and infants, as it is one of the first to colonize the gut. | Commonly found in adults, has a long-term impact on gut health and immune modulation. |
Unique Functions | Suppresses harmful pathogens and improves gut motility, effective for managing bloating and constipation. | Balances gut flora, supports overall digestive function, and produces both acetate and lactate. |
Both B. bifidum and B. longum act primarily by producing SCFAs, which lower the pH of the gut, preventing the growth of harmful bacteria and creating a favorable environment for beneficial microorganisms. They also strengthen the gut lining by stimulating mucin production, enhancing intestinal barrier function.
Both strains interact with the immune system by influencing the production of cytokines, which modulate inflammation and immune responses. Additionally, they contribute to improved digestion by aiding in the breakdown of complex carbohydrates, thereby increasing nutrient availability for the host.
When combined, B. bifidum and B. longum may provide complementary effects that enhance gut health. B. bifidum supports motility and pathogen suppression, while B. longum contributes to immune modulation and promotes a balanced gut flora. This synergy may improve the overall efficacy of probiotic supplementation.
Both B. bifidum and B. longum promote a balanced microbiome by supporting beneficial bacteria and inhibiting harmful pathogens. Their ability to ferment carbohydrates and produce SCFAs enhances gut health by improving digestion and preventing gastrointestinal disturbances like bloating and constipation.
Both strains possess anti-inflammatory properties that support the immune system. By modulating the production of pro-inflammatory cytokines, B. bifidum and B. longum contribute to a balanced immune response and may alleviate symptoms of chronic inflammatory conditions like IBD and IBS.
Recent research have explored the effects of B. bifidum and B. longum on brain health, particularly in the context of neurodegenerative diseases like Alzheimer's. A study demonstrated that the administration of B. bifidum BGN4 and B. longum BORI improved cognitive and memory functions in a mouse model of Alzheimer's disease. This study suggests that these probiotics may influence the gut-brain axis, potentially offering new insights into how gut microbiota impacts cognitive health. Creative Biolabs offers professional germ-free mouse model testing services, click to learn more.
Fig.1 B. bifidum BGN4 and B. longum BORI reduced Alzheimer's disease (AD) pathogenesis in the 5xFAD Mouse Brain.1
Emerging research suggests that these strains may also have broader health benefits. For example, B. bifidum has been linked to improved mental health through the gut-brain axis, while B. longum may support metabolic function, including improved glucose metabolism and fat regulation.
The choice between B. bifidum and B. longum depends on individual health needs:
CAT# | Product | Description |
---|---|---|
LBP-008CYG | Bifidobacterium bifidum Powder | Freeze-dried B. bifidum powder, ideal for probiotic applications. |
LBST-049FG | Bifidobacterium bifidum Baby Feces | B. bifidum isolated from baby feces. It is a Gram-positive, anaerobic bacterium essential for gut health. |
LBST-050FG | Bifidobacterium bifidum Human Feces | B. bifidum isolated from human feces. A Gram-positive, anaerobic bacterium that supports healthy digestion. |
LBST-051FG | Bifidobacterium bifidum 20215 | B. bifidum isolated from adult intestine. An essential bacterium found in the human intestine for gut health. |
LBST-052FG | Bifidobacterium bifidum Intestine | B. bifidum isolated from the intestine. A critical bacterium for maintaining gut microbiota balance. |
LBP-009CYG | Bifidobacterium longum susp. infantis Powder | Freeze-dried B. longum susp. infantis Powder |
LBST-056FG | Bifidobacterium longum; Microbial inoculum | B. longum was isolated from microbial inoculum. It is a Gram-positive, catalase-negative, rod-shaped bacterium. It is a microaerotolerant anaerobe and considered to be one of the earliest colonizers of the gastrointestinal tract of infants. |
LBGF-0722-GF65 | Bifidobacterium longum | B. longum is a Gram-positive, catalase-negative, rod-shaped bacterium. It is a microaerotolerant anaerobe and considered to be one of the earliest colonizers of the gastrointestinal tract of infants. |
LBGF-0722-GF10 | Bifidobacterium longum subsp. longum | B. longum was isolated from microbial inoculum. It is a Gram-positive, catalase-negative, rod-shaped bacterium. It is a microaerotolerant anaerobe and considered to be one of the earliest colonizers of the gastrointestinal tract of infants. |
References
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.